HOME >> BIOLOGY >> NEWS
Plant-like enzyme acts as key life cycle switch in malaria parasite

An essential switch in the life cycle of the malaria parasite has been uncovered by researchers in England, Germany and Holland.

They have established that to infect mosquitoes that transmit malaria, the parasites depend on a type of molecule normally found in plants, which they have named Calcium-Dependent Protein Kinase 4 (CDPK4).

The finding, based on studies of the malaria parasite of rodents, Plasmodium berghei, is described as basic science, but the authors suggest it may give drug researchers a specific and safe target against which to screen potential anti-malarial drug compounds.

The findings are reported in today's edition of the journal Cell (14 May) by researchers from Imperial College London, Leiden University Medical Center, Netherlands, and the Max-Planck Institute of Infection Biology, Germany.

"This work identifies the first signalling molecule that we know is essential for the transmission of the parasite," says Dr Oliver Billker, research fellow and lead author, from Imperial College London.

"It is an essential molecule because if the malaria parasite doesn't have this gene function then transmission of the parasite to mosquitoes is completely disrupted. It is also specific to development of the male gametes only."

"CDPK4 is unusual because apart from the malaria parasite and some other single-celled organisms, it is only seen in plants. This makes it appealing as a target for drug developers, who would not run such a big risk of developing a drug with strong side effects, because CDPK4-like molecules do not exist in humans."

The human malaria parasite has two hosts, humans and mosquitoes. Just after the mosquito has taken a blood meal from a human, malaria parasites in the mosquito bloodstream differentiate into male and female sexual forms, named micro- and macro-gametes respectively.

In 1997, Imperial College researchers discovered that the mosquito molecule xanthurenic acid
'"/>

Contact: Tom Miller
t.miller@imperial.ac.uk
44-207-594-6704
Imperial College London
13-May-2004


Page: 1 2

Related biology news :

1. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
2. First glimpse of DNA binding to viral enzyme
3. Two enzymes key to calorie-burning, Brown research shows
4. Argonne scientists determine structure of staph, anthrax enzyme
5. Brain serotonin enzyme finding might explain psychiatric disorders
6. Study finds plant enzyme function changes with location in cell
7. Basic RNA enzyme research promises single-molecule biosensors
8. Molecule that blocks key bacterial enzyme may lead to new antibiotics
9. Study finds first evidence COX-2 enzymes can regulate DNA damage
10. UNC scientists block cellular enzyme activity involved in cancer progression
11. ADAM: Good enzyme for Alzheimer disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... Justin Zamirowski to lead ... near term focus on Type 2 diabetes and associated comorbidities. , Justin brings ... areas and classes. As Chief Commercial Officer, Justin will lead Better Therapeutics’ ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... Today CJ ... Advantage, which will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient ... The Umami Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) ...
(Date:7/1/2020)... ... 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit ... aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: John ... the organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Bode Technology, a leading provider ... through its COVID-19 testing service, Bode-CARES . Bode-CARES combines high-volume clinical testing ... provides a turnkey solution that includes a comprehensive collection and virus-management program for ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... Colo. (PRWEB) , ... June ... ... of expert tissue data insights, today announced that the launch of a ... results along with data about the tumor microenvironment (TME). , “Flagship’s TissueInsight ...
(Date:6/28/2020)... ... June 26, 2020 , ... ... solutions providers, today announced its strong opposition to the recently introduced bicameral ... a blanket ban on most federal use of nearly all biometric and related ...
Breaking Biology Technology:
Cached News: